N-cyclopropyl-N-methylcarbamoyl chloride | 71682-16-1

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: N-cyclopropyl-N-methylcarbamoyl chloride
• 英文别名: cyclopropyl(methyl)carbamic chloride；N-methyl-N-cyclopropylcarbamoyl chloride
• CAS: 71682-16-1
• 化学式: C₅H₈ClNO
• 分子量: 133.578
• InChiKey: LDSGUMIQVUMQIM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  8
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.8
• 拓扑面积：
  20.3
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  N-cyclopropyl-N-methylcarbamoyl chloride 在 N,N-二异丙基乙胺 、 N,N'-羰基二咪唑 作用下， 以 四氢呋喃 、 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 反应 14.0h， 生成 (S)-1-(cyclopropyl(methyl)carbamoyl)pyrrolidin-3-yl (1-(4- (2,6-dioxopiperidin-3-yl)-3,5-difluorophenyl)azetidin-3-yl)carbamate
  参考文献：
  名称：

  WO2024092039A1

  摘要：

  公开号：
• 作为产物：
  描述：

  三光气 、 N-甲基环丙胺 在 吡啶 作用下， 生成 N-cyclopropyl-N-methylcarbamoyl chloride
  参考文献：
  名称：

  [EN] CDK2 INHIBITORS AND METHODS OF USING THE SAME
  [FR] INHIBITEURS DE CDK2 ET LEURS PROCÉDÉS D'UTILISATION

  摘要：

  The present disclosure provides compounds, compositions thereof, and methods of using the same for the inhibition of CDK2, and the treatment of CDK2 related diseases and disorders.

  公开号：

  WO2024026484A2

文献信息

• O-alkoxy- and alkylthiophenyl carbamates
  申请人：Velsicol Chemical Corporation

  公开号：US04163112A1

  公开（公告）日：1979-07-31

  This invention discloses new chemical compounds of the formula ##STR1## wherein R.sup.1 is selected from the group consisting of hydrogen, alkyl and alkenyl; R.sup.2 is selected from the group consisting of alkyl, alkenyl, cycloalkyl and ##STR2## WHEREIN Z is selected from the group consisting of alkyl, alkenyl, alkoxy, halogen, nitro and alkylthio; p is an integer from 0 to 5; and m is the integer 0 or 1; X.sup.1 and X.sup.2 are each selected from the group consisting of hydrogen, alkyl and halogen; Y is selected from the group consisting of oxygen and sulfur; n is the integer 1 or 2; and R.sup.3 and R.sup.4 are each alkyl.

  这项发明揭示了新的化学化合物，其化学式为##STR1##其中R.sup.1选自氢、烷基和烯基组成的群；R.sup.2选自烷基、烯基、环烷基和##STR2##其中Z选自烷基、烯基、烷氧基、卤素、硝基和烷硫基组成的群；p为0至5的整数；m为整数0或1；X.sup.1和X.sup.2各自选自氢、烷基和卤素组成的群；Y选自氧和硫组成的群；n为整数1或2；R.sup.3和R.sup.4各自为烷基。
• Tetrazolinones as herbicides and intermediates
  申请人：NIHON BAYER AGROCHEM K.K.

  公开号：EP0820994A1

  公开（公告）日：1998-01-28

  The present invention relates to novel compounds and mixtures of geometrical isomers, which are represented by the formula: wherein R1 and R2independently of one another are C1-6 alkyl, C1-6 haloalkyl, C3-8 cycloalkyl, C2-6 alkenyl, C2-6 haloalkenyl, C3-6 alkynyl or optionally substituted phenyl; or R1 and R2, together with the nitrogen atom to which they are bonded, form a 5-membered or 6-membered heterocyclic ring which may be benzo-fused or which may be substituted by halogen or C1-4 alkyl; R3 is hydrogen or C1-6 alkyl; R4 is hydrogen or C1-6 alkyl; or R3 and R4, together with the carbon atoms to which they are bonded, form cyclopentylidene or cyclohexylidene; and R5 is C1-6 alkyl, C3-6 alkenyl or benzyl; further to processes and new intermediates for their production and to their use as herbicides.

  本发明涉及一类新的化合物及几何异构体的混合物，其由以下公式表示：其中R1和R2彼此独立地为C1-6烷基，C1-6卤代烷基，C3-8环烷基，C2-6烯基，C2-6卤代烯基，C3-6炔基或可选地被取代的苯基；或者R1和R2与它们所连接的氮原子一起形成一个可能被苯并环合的、5成员或6成员的杂环环，该环可能被卤素或C1-4烷基取代；R3是氢或C1-6烷基；R4是氢或C1-6烷基；或者R3和R4与它们所连接的碳原子一起形成环戊基亚基或环己基亚基；并且R5是C1-6烷基，C3-6烯基或苄基；进一步涉及到它们的制备过程和新中间体，以及它们作为除草剂的使用。
• [EN] METABOTROPIC GLUTAMATE RECEPTOR MODULATORS<br/>[FR] MODULATEURS DES RÉCEPTEURS GLUTAMATERGIQUES MÉTABOTROPES
  申请人：MERZ PHARMA GMBH & CO KGAA

  公开号：WO2012085167A1

  公开（公告）日：2012-06-28

  The invention relates to heterocyclic derivatives as well as their pharmaceutically acceptable salts. The invention further relates to a process for the preparation of such compounds. The compounds of the invention are m GluR5 modulators and are therefore useful for the control and prevention of acute and/or chronic neurological disorders.

  这项发明涉及杂环衍生物及其药用可接受的盐。该发明还涉及一种制备这类化合物的方法。该发明的化合物是mGluR5调节剂，因此对于控制和预防急性和/或慢性神经系统疾病是有用的。
• [EN] INGENOL-3-ACYLATES III AND INGENOL-3-CARBAMATES<br/>[FR] INGÉNOL-3-ACYLATES III ET INGÉNOL-3-CARBAMATES
  申请人：LEO PHARMA AS

  公开号：WO2012083953A1

  公开（公告）日：2012-06-28

  The invention relates to compounds of general formula I wherein R is heteroaryl optionally substituted by R7; or R is heterocycloalkyl or heterocycloalkenyl, optionally substituted by R8; or R is X wherein X is -NR11R12; and pharmaceutically acceptable salts, hydrates, or solvates thereof, for use -alone or in combination with one or more other pharmaceutically active compounds- in therapy, for preventing, treating or ameliorating diseases or conditions responsive to stimulation of neutrophil oxidative burst, responsive to stimulation of keratinocyte IL-8 release or responsive to induction of necrosis.

  该发明涉及一般式I的化合物，其中R为杂环芳基，可选择地由R7取代；或R为杂环烷基或杂环烯基，可选择地由R8取代；或R为X，其中X为-NR11R12；以及其在治疗中的药物可接受的盐、水合物或溶剂合物，用于单独使用或与一个或多个其他药用活性化合物结合在一起，用于预防、治疗或改善对中性粒细胞氧化爆发的刺激响应、对角质细胞IL-8释放的刺激响应或对坏死诱导的刺激响应的疾病或症状。
• INGENOL-3-ACYLATES III AND INGENOL-3-CARBAMATES
  申请人：Grue-Sørensen Gunnar

  公开号：US20140303150A1

  公开（公告）日：2014-10-09

  The invention relates to compounds of general formula I wherein R is heteroaryl optionally substituted by R7; or R is heterocycloalkyl or heterocycloalkenyl, optionally substituted by R8; or R is X wherein X is —NR11R12; and pharmaceutically acceptable salts, hydrates, or solvates thereof, for use—alone or in combination with one or more other pharmaceutically active compounds—in therapy, for preventing, treating or ameliorating diseases or conditions responsive to stimulation of neutrophil oxidative burst, responsive to stimulation of keratinocyte IL-8 release or responsive to induction of necrosis.

  本发明涉及一般式I的化合物，其中R是杂环芳基，可选择由R7取代; 或R是杂环烷基或杂环烯基，可选择由R8取代; 或R是X，其中X是—NR11R12;以及其药学上可接受的盐、水合物或溶剂化物，用于治疗，单独或与一个或多个其他药学活性化合物联合使用，预防、治疗或改善对嗜中性粒细胞氧化爆发刺激、对角质细胞IL-8释放刺激或对坏死诱导反应的疾病或病情的响应。